BMI View: South Africa boasts the largest pharmaceutical market in Africa, and already has a wellestablished
manufacturing industry supported by foreign investment. An improving regulatory environment,
promising economic growth and high per capita spending will all co ..."
BMI View: Continued delays towards large-scale regulatory improvements in South Africa's
pharmaceutical industry pose a threat to generic medicines market growth; however, long-term growth will
be supported through a variety of other driving factors including cost-con ..."
BMI View: A compulsory licence for Aluvia in South Africa remains unlikely given that country's
reluctance to resort to such measures. The request puts pressure on AbbVie to address supply issues, but
more importantly reminds South Africa's government that expectation ..."
BMI View: Delays in implementing South Africa's national health insurance scheme and intellectual
property reform will negatively impact patients' access to medical treatments in the short term. Despite
these impediments, innovative drugmakers and private healthcare p ..."
BMI View: Improvements to South Africa's pharmaceutical supply chain will result in fewer drug
shortages, making the country a more attractive destination for local manufacturing. Inequalities will still
persist between states, with further drug shortages more likely ..."
BMI View: The continued commitment of the South African government to boosting spending on healthcare
will be the primary driver for the growth of the pharmaceutical market in 2015. Although lower oil prices
will improve the consumer environment for lower cost medicin ..."
BMI View: Internationalisation will become a critical element in the business strategies of South Korean
drugmakers due to pricing controls in the domestic market and the strong commercial opportunities in
developing economies. We highlight the importance of emerging ..."
BMI View: A cooling economy, rising unemployment and a worsening consumer outlook will limit the
South African pharmaceutical market's potential in the short term. However, the government's commitment
to an expansive fiscal policy, particularly to spending on healthcare infrast ..."
GlobalData, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – South Africa”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landsc ..."
BMI View: South Africa is the best investment opportunity for multinational drugmakers seeking to enter
the African market - boasting the largest medicines market on the continent and poised for high single-digit
growth over the next decade.
Headline Expenditure ..."